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The Mj muscarinic acetylcholine receptor mutant (M, mutant), with a lack of glycosyla-
tion sites, a deletion in the central part of the third inner loop, and the addition of a six
histidine tag at the C-terminus, was fused to maltose binding protein (MBP) at its N-ter-
minus and expressed in Escherichia coli. The expression level was 0.2 nmol receptor per
100 ml culture, as assessed as [sH]L-quinuclidinyl benzilate (["HIQNB) binding activity,
when the BL 21 strain was cultured at 37*C to a late growth phase and the expression
was induced by isopropyl fi-thiogalactoside at 20"C. No [3HJQNB binding activity was
detected when it was not fused to MBP or when expression was induced at 37*C instead
of 20'C. The MBP-Mj mutant expressed in E. coli showed the same ligand binding activ-
ity as the Mj mutant expressed in the Sporodoptera frugiperda (Sf9)/baculovirus system,
as assessed as displacement of [3H]QNB with carbamylcholine and atropine. The MBP-
M, mutant was solubilized, purified with Co2+-immobilized Chelating Sepharose gel and
SP-Sepharose, and then reconstituted into lipid vesicles with G protein Go or G(1 in the
presence or absence of cholesterol. The reconstituted vesicles showed GTP-sensitive
high affinity binding for carbamylcholine and carbamylchoUne-stimulated [^flGTPyS
binding activity in the presence of GDP. The proportion of high affinity sites for carbam-
ylcholine and the extent of carbamylcholine-stimulated [^ SJGTPyS binding were the
same as those observed for the M, mutant expressed in Sf9 cells and were not affected
by the presence or absence of cholesterol. These results indicate that the MBP-M,
mutant expressed in E. coli has the same ability to interact with and activate G proteins
as the Mg mutant expressed in Sf9, and that cholesterol is not essential for the function
of the Mj muscarinic receptor.
Key words: cholesterol, Escherichia coli, G protein-coupled receptor, muscarinic acetyl-
choline receptor, reconstitution.
G protein-coupled receptors (GPCRs) are known to be in-
volved in diverse functions (1, 2). The ligands for GPCRs
include transmitters, hormones, pheromones, and odors.
Upon ligand binding, GPCRs activate heterotrimeric G pro-
teins by catalyzing GDP-GTP exchange on their a subunits
(Got), thereby causing dissociation of the a and fty subunits
(Gffy). Ga and Gpy activate or inhibit enzymes that give
rise to the formation or breakdown of the second messen-
gers in cells and regulate ion channels in cell membranes.
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The muscarinic acetylcholine receptor belongs to this
superfamily of GPCRs. There are five subtypes of muscar-
inic receptors (3, 4): the M,, M^ and Mj subtypes couple to
G^Gn type G proteins, and the M^ and M4 subtypes couple
to G/Go type G proteins. Muscarinic receptors are broadly
expressed from peripheral tissues such as salivary glands
(M, and M,), sweat glands (M^, ileum (Mj, M,), and heart
(Mj), to the central nervous system (Mj-Mg).
The expression levels of GPCRs are usually less than 1
pmol/mg protein. The development of a high expression
system is essential for molecular characterization of
GPCRs including muscarinic receptors, particularly for
structural studies involving electron or X ray crystaUogra-
«Us 1*« S f 9 h a s heen successfully used for large
expression of GPCRs {5-8). Muscannic receptors have been
expressed in this system, and have been shown to have the
same ligand binding and G protein activating activity as
^ose extracted from mammalian tissues or expressed in
m a m m a l i a n cultured cells (5, 9, 10). However, considering
***
 bme 3nd cost
 squired for cultunng Sf9 cells, a more
easily handled expression system is desirable. Muscarinic
receptors have also been expressed in Saccharomyces cere-
uisiae {11) and BY 2 tobacco cells {12), although the expres-
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sion levels in both systems were low: 20 finol/mg protein for
iS. cerevisiae and 2.0-2.5 pmol/mg protein for BY 2 tobacco
cells. Because of its ease in culturing, E. coli is considered
to be one of the most efficient expression systems for
acquiring proteins of interest. There have been several
reports on the expression of GPCRs in E. coli (13). The fe-
adrenergic receptor was first expressed among GPCRs and
was found to retain ligand binding activity (14). The SHT^
receptor expressed in E. coli was reported to interact with
G proteins (15). However, the expression levels in these
studies were low. Grisshammer et at. have shown that a
relatively high amount of neurotensin receptor can be
expressed in E. coli through the fusion of MBP at the N-
terminus of the receptor (15 pmol/mg protein) (16,17). The
Mj muscarinic receptor (18) and dopamine D2 receptor (Ito
and Haga, unpublished data) have also been expressed suc-
cessfully using the same strategy as for the neurotensin
receptor. These receptors have been shown to have the
same ligand binding activity as mammalian receptors, but
it remains unknown if they have the same ability to inter-
act with G proteins. In the present study, we have ex-
pressed the M2 muscarinic receptor as a MBP fusion pro-
tein in E. coli using the strategy used for the expression of
neurotensin receptors (16, 17). The expressed receptor,
which was purified and reconstituted into lipid vesicles,
was found to have the same ligand binding and G protein
activating activities as the Mj muscarinic receptor ex-
pressed in Sf9 cells.
We have also examined if cholesterol is necessary for the
function of muscarinic receptors. Cholesterol, either by
changing the physical properties of biological membranes
or by directly interacting with proteins, can modulate the
function of membrane proteins (19). A well known example
is the nicotinic acetylcholine receptor, which loses its cation
channel function in the absence of cholesterol (20, 21).
There have been several reports on the role of cholesterol in
the function of GPCRs: for some receptors including /?-ad-
renergic (22), muscarinic (23), and oxytosin receptors (24-
26), cholesterol has been reported to be required for reten-
tion of ligand binding activity or for increasing the affinity
of receptors for ligands, and for other receptors including
dopamine D, receptor (27) and rhodopsin (28), cholesterol
has been reported to inhibit their activation. These results
were obtained through experiments involving membrane
preparations or proteoliposomes in which detergent-solubi-
lized proteins were reconstituted, and these preparations
may contain various levels of cholesterol. Definite answers
regarding the requirement of cholesterol should be ob-
tained through experiments involving the reconstitution of
purified and cholesterol-free GPCRs and G proteins in a
defined composition of lipids. We took advantage of the fact
that the membrane of E. coli does not contain any choles-
terol (29). Here, we provide evidence that the muscarinic
receptor can activate G proteins in the absence of choles-
terol.
MATERIALS AND METHODS
Materials—PET25b(+), BL 21, and BL2KDE3) were pur-
chased from Novagen; pGEX-2T, Chelating Sepharose fast
flow, SP-Sepharose, and Sephadex G50 from Pharmacia;
GTP, GTPyS, GDP, PC, PI, cholesteryl hemisuccinate,
CHAPS, and digitonin from Sigma; sodium cholate from
WAKO; PH]NMS, PH]QNB, and pSJGTPyS from NEN
Dupont; His-probe and Goat antd rabbit IgG (horseradish
peroxidase) from Santa Cruz; PVDF membranes from Mil-
lipore; and GF/B glass fiber filters from Whatman. The
pRG/E-MBP and pT-Trx vectors were kind gifts from Dr.
Grisshammer (MRC Center, Cambridge, UK) and Dr. Ishii
(RIKEN, Tsukuba), respectively.
Strains, Expression Vectors, and Culture Conditions—
The expression vector pRG/TI-MBP was used in the present
experiment. This expression vector contained most of MBP
under the control of the lac promoter and the double riboso-
mal binding site of the vector pASK40 (17). We used the Mr,
muscarinic receptor mutant (Mj mutant), MjtN-D)-
(6HisXI3del) (10), in which most of the third internal loop
(233-380) was deleted, a six histidine tag (6xHis) and a
thrombin cleavage site were added to the C-terminus, and
Asn 2, 3, 6, and 9 were replaced by Asp to prevent N-g\yco-
sylation (Fig- la) (10). Various expression vectors were con-
structed to express the Mj mutant (Fig. lb).
The Mj mutant starting from Asp 2 was fused to MBP at
its N-terminus between the BamHI and Pstl sites of the
pRG/H-MBP vector (pRGH/MBP-Mj mutant). The same
coding sequence as that of the pRGD/MBP-M^ mutant was
inserted down stream of the T7 promoter and a ribosomal
binding site of PET25b(+) between the Ncol and HindUl
sites. The resultant vector, the PET25(+)-MBP-M2 mutant,
contained a pel B signal sequence (30) at its N-terminus.
The PET25(+)-MBP-Ms mutant was digested with Ndel
and Ncol, followed by blunt ending and ligation to remove
sequences that encode pel B to construct the PET25(-)-
MBP-Mj mutant. The PET25(+)-M2 mutant was con-
structed by inserting the whole sequence of the M^ mutant
between the Ncol and HmdlTJ sites of PET25b(+). The
thioredoxin (Trx) sequence derived from E. coli strain K12
was isolated from the vector pT-Trx, which includes Trx
under the control of the T7 promoter (31), by PCR. The
resultant Trx gene was inserted into the C-terminus of the
MBP-M^ mutant between the Notl and HindUl sites
[pRGE/MBP-Mj mutant-Trx(+His)]. The pRGD/MBP-M,
mutant-Trx(-His) did not include 6xHis between the Mj
mutant and Trx. GST was also inserted into the N-termi-
nus of the Mj mutant. The pGEX-2T vector was digested
with .BamHI and EcoRI, and then blunt-ended. The whole
sequence of the M^ mutant (between Ncol and PstT) was
blunt-ended and then inserted into the vector (pGEX-Mj
mutant).
The pRGHAMBP and pGEX based vectors were trans-
formed into BL21, and the PET25X+ or -KMBP-M;, mutant
and PET25b(+) based vectors were transformed into BL21
(DE3) and selected for ampicillin resistance. Also, for co-
expression of thioredoxin, both the pRGII/MBP-M^ mutant
and pT-Trx were transformed into BL2KDE3) and selected
for both ampicillin and chloramphenicol resistance. BL21
was grown in 2xTY medium containing 50 ug/ml ampicillin
at 37°C until O D ^ became 1.4. Then, the incubation tem-
perature was reduced to 20°C and isopropyl pMMogalacto-
side (IPTG) was added to 0.5 mM. The cells were harvested
24 h later and stored at -80*C. The Mj mutant was ex-
pressed in Sf9/baculovirus, in the same manner as previ-
ously described (5,10).
Membrane Preparation—Spheroplasts were obtained by
the method as described previously (32, 33). The cell pellet
derived from 1 liter culture was resuspended in 100 ml of a
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MBP-M2 mutant-
Trx(+/-Hb)
Ml mutant
T7
tac GST
M2 mutant
I M2 mutant
PET25(-)-M2 mutant
(M2 mutant)
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Fig. 1. Topology of the Mj mutant and the expression constructs, (a) The mutations of the M? muscarinic receptor included deglycosi-
lation at the N-terminal domain, deletion of the central part of the third inner loop, and the addition of a thrombin cleavage site and a
6xhistidine tag. (b) Various fusion receptors with various promoters were obtained for expression.
buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA,
25% sucrose, 0.5 mM phenylmethylsulphonyl fluoride, and
60 ug/ml lysozyme, and stirred at 4'C for 1 h. An equal
amount of cold deionized water was added and then mild
sonication was performed [30 s on and 2 min off at level 5
for three times, with a Tomy ultrasonic disrupter (UD-
200)]. The membrane fraction was collected by centrifuga-
tion at 150,000 xg at 4'C for 1 h. The pellet was resus-
pended in 100 ml of a buffer containing 20 mM Tris-HCl
(pH 7.4), 500 mM NaCl, and 1 mM EDTA, and then centri-
fuged at 150,000 xg at 4'C for 1 h. The pellet obtained on
the last centrifugation was resuspended in 25 ml of 20 mM
Tris-HCl (pH 7.4).
Ligand Binding Assay—The membrane fraction was
assayed for its ability to bind to muscarinic antagonists,
PH]QNB or PH] iV-methylscopolamine (pH]NMS). The
method for the binding assay was described previously (34).
The membrane (20 ul from the above suspension) was incu-
bated in 1 ml of 20 mM potassium phosphate buffer (KPB)
(pH 7.0) containing PH]QNB or PH]NMS at 30°C for 1 h.
PH]QNB or PH]NMS bound to receptors was trapped on a
GF/B glass fiber filter and then the radioactivity was mea-
sured with a liquid scintillation counter.
The membrane fraction was solubilized with 1% digito-
nin and 0.3% sodium cholate at 2 mg/ml protein concentra-
tion. The solubilized receptor (10 ul) was incubated in 200
ul of a buffer containing 20 mM potassium phosphate
buffer (pH 7.0), 100 mM NaCl, 0.1% digitonin and PH]QNB
or PHJNMS at 30"C for 1 h with different concentrations of
carbamylcholine and atropine. PHIQNB or pHJNMS bound
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to solubilized receptors was recovered in the void volume
fraction from a Sephadex G50 column and then the radio-
activity was measured with a liquid scintillation counter.
Western Blot Analysis—The MBP-Mj mutant was solubi-
lized with 1% Triton X100 at 4 mg/ml protein concentra-
tion. The solubilized fraction (30 ul) was subjected to SDS-
PAGE on a 12% polyacrylamide gel and then transferred to
a polyvinylidene difluoride membrane. After blocking with
skim milk, the membrane was incubated with 0.05 ug/ml
polyclonal antibodies against 6xHis, His-probe, followed by
0.4 ug/ml of goat anti rabbit IgG labeled with horseradish
peroxidase. Bands were visualized by staining the mem-
brane with dimethylaminoazobenzene.
Purification of the MBP-M2 Mutant by Co2*-Immobilized
Chelating Sepharose Gel and Cation Exchange Chromatog-
raphy—Co2+-immobihzed Chelating Sepharose gel was pre-
pared by loading a 5x volume of 0.2 M CoC^ onto Chelating
Sepharose gel. The solubilized MBP-RL, mutant (100 ml),
which was derived from 1 liter of culture and contained
approximately 2 nmol of receptor, was loaded onto a 2 ml
column volume of Co2+-immobih'zed Chelating Sepharose
gel at 30 ml/h. The column was washed with 20 ml of a
buffer containing 20 mM Tris-HCl, 500 mM NaCl, 0.1%
digitonin, and 10 mM imidazole (pH 7.4) at the same flow
rate. The receptor was eluted with 10 ml of a buffer con-
taining 50 mM imidazole buffer (pH 7.0), 500 mM NaCl,
and 0.1% digitonin. The eluted fraction was diluted 20-fold
with a buffer containing 10 mM Mes-KOH (pH 6.0) and
0.1% digitonin and loaded onto a 0.5 ml column volume of
SP-Sepharose at approximately 30 ml/h. The column was
washed with 5 ml of a buffer containing 10 mM Mes-KOH
(pH 6.0), 50 mM NaCl, and 0.1% digitonin, and eluted with
2.5 ml of a buffer containing 20 mM Tris-HCl (pH 8.0), 300
mM NaCl, and 0.1% digitonin. The peak fraction was col-
lected.
The Mj mutant was purified by Co2+-immobilized Chelat-
ing Sepharose gel essentially by the same method as above.
The expression of the Mj mutant in Sf9/baculovirus and the
isolation of the membrane fraction were performed by
means of the methods previously described (5).
Reconstitution of the MBP-M2 Mutant and G Protein Go
or Glt—The reconstitution method was essentially the
same as that previously reported (23, 35). G proteins were
purified from porcine brain as described previously (36).
Phosphatidylcholine (PC), phosphatidylinositol (PI), and
cholesteryl hemisuccinate or PC and PI were dissolved in a
chloroform and methanol solution [2:1 (v/v)] at 12:12:1 (w/
w) or 1:1, respectively. The chloroform and methanol were
evaporated off under constant N2 aeration, and the result-
ing lipid film was suspended in a buffer containing 20 mM
Hepes-KOH (pH 8.0), 1 mM EDTA, 160 mM NaCl (HEN),
and 1% sodium cholate (Wako) at 4 mg/ml total lipid con-
centration. The purified MBP-Mj mutant or the NL, mutant
(10 pmol) was mixed with 75 to 100 pmol of Go or Ga in
0.7% CHAPS in HEN supplemented with 20 mM MgCL,, 10
mM DTT, 2 mg/ml of the lipid mixture and 1 mM carbam-
ylcholine. The mixture (200 ul total volume) was run
through Sephadex G50 pre-equilibrated with HEN. The
void volume fraction was collected, and used as the recon-
stituted vesicles.
PHJQNB and ^SlGTP-fi Binding Assaying of the Recon-
stituted Receptor—The reconstituted vesicles were incu-
bated with 1.5 nM PHJQNB at 30°C in HEN containing 10
mM MgCL, and 5 mM DTT with or without 100 uM GTP in
the presence of various concentrations of carbamylcholine
or atropine in a 1 ml total reaction volume. For the
P'SlGTPyS binding assay, the vesicles were incubated in
HEN containing 10 mM MgCL,, lmM DTT, 50 nM
[^SJGTPyS, and 5 uM GDP in the presence of 1 mM car-
bamylcholine or 10 uM atropine at 30°C for 0, 2, 5,10, or 20
min. The total reaction volume was 100 ul. The reaction
was stopped by the addition of 500 ul of HEN containing
100 uM GTP. In both the PH]QNB and PSlGTPyS binding
assays, the vesicles after the reaction were trapped on GF/
B glass fiber filters and then the radioactivity was mea-
sured with a liquid scintillation counter.
RESULTS
Expression of the MBP-M2 Mutant—The expression lev-
els of various fusion receptors are summarized in Table I.
The Mj mutant, rather than the wild type Mj, receptor, has
been expressed because the wild type Mj receptor tends to
undergo degradation (most likely at the third intracellular
loop region) during the purification process. Two strains of
E. coli, BL 21 and DH 5, were examined for expression of
the MBP-M^ mutant under the same culture conditions.
The expression level of the MBP-Mj mutant was 1.5-fold
higher in BL21 than in DH 5, so we used BL 21 throughout
this work. The cells were grown at 37"C to a late growth
TABLE I. Expression of the fusion M, mutants in E. coli. Various constructs were examined for expression. In this study, the BL21 or
BL21CDE3) strain was cultured in 2xTY medium containing 50 ug/ml ampidllin at 37°C until OE ,^,, 1.4 was reached. The culture temperature
was reduced to 20°C and expression was induced with 0.5 mM IPTG for 24 h. The membrane fraction was collected, and assayed for [*H]QNB
binding and subjected Western blotting with the His-probe (+) or (-) for Western blotting corresponds to detection or non-detection of bands.
Abbreviations: N.D., not determined; N.A. not applicable *The induction was carried out for 4 h instead of 24 h. **Trx was co-expressed with the
MBP-M, mutant.
Constructs Promoters Induction temperature CO [*H]QNB binding pmol/100 ml culture Western blotting
MBP-Mj mutant
MBP-Mj mutant-Trx(+His)
MBP-M, mutant-Tnrf-His)
MBP-Mj mutant+Trx"*
MBP-Mj mutant
pelB-MBP-Mj mutant
pelB-Nt, mutant
Mj mutant
GST-Ms mutant
lac
lac
lac
lac
T7
T7
T7
T7
tac
20
25
37°
20
20
20
20
20
20
20
20
220 ± 40 (3)
115 ± 14 (2)
3 ±0(2)
188 ± 15 (2)
202 ± 32 (2)
200 ± 10 (2)
92 ± 16 (2)
85 ± 14 (2)
0
0
0
N.D.
N.D.
+
NA.
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phase (ODJOO = 1.4), and incubated with 0.5 mM IPTG at
20'C for 24 h to induce the expression of the MBP-Mj
mutant. This culturing condition gave the best yield of the
MBP-Mj mutant among the conditions examined, such as
those on induction of the expression at a lower cell density
and for a longer time (Fig. 2). The membrane fraction
derived from 100 ml of culture exhibited 0.2 nmol PH]QNB
binding sites (6 pmol/mg of protein). The expression level of
the MBP-1VL, mutant decreased to 50% or less when the
cells were treated with 0.5 mM IPTG at 25"C instead of
20'C. Very little PH]QNB binding activity (less than 5 pmol
in 100 ml of culture) was observed when the cells were
treated with 0.5 mM IPTG at 37'C for 4 h. The co-expres-
sion of Trx, which was derived from the E. coli K 12 strain,
did not improve the expression level of the MBP-Mj
mutant. The fusion of Trx or 6xHis and Trx to the C-termi-
nus of the MBP-M;, mutant was also not effective in
increasing the expression level. This is in contrast with in
the case of the neurotensin receptor, whose expression level
was reported to increase on fusion of Trx to the C-terminus
(17). The expression level of the M B P - ^ mutant under the
T7 promoter in the BL 21(DE3) strain was 2-fold lower
compared to that of the MBP-Mj mutant under the lac pro-
moter in the BL 21 strain. The expression of the Mj mutant
without MBP fusion was not detected in the PH]QNB bind-
ing assay for the membrane preparation of E. coli. The
expression of the MBP-M, mutant was further verified by
Western blotting with polyclonal antibodies against 6xHis.
A clear band appeared approximately at the position of the
expected molecular weight (approximately 80 kDa) (Fig. 3).
No band for the Mj mutant was detected for the membrane
preparation of E. coli, while a band was detected for the Mj
mutant from Sf9. Expression of the GST-M2 mutant was
observed on Western blotting, but no PH]QNB binding ac-
tivity was detected (data not shown).
Solubiluation and Purification of the MBP-M2 Mutant
from E. coli and the M2 Mutant from Sf9 Cells—The MBP-
M? mutant was solubilized with a buffer containing 1% dig-
itonin and 0.3% sodium cholate at the protein concentra-
tion of 2 mg/ml. Eighty to ninty percent of the MBP-Mj
mutant was extracted from the membrane fraction, as
10 20 25 30 35 40
Time of Induction (b)
45 50
Fig. 2. Culture conditions and expression levels. Induction
with 0.5 mM IPTG was carried out at various OD,,,, values (O = 0.6,
C = 1.0, A = 1.4, x = 1.8) and for various lengths of time. The graph
shown is representative of two experiments.
assessed as PH]QNB binding activity. The MBP-M;, mutant
was purified on Ck)2+-immobilized Chelating Sepharose gel
and SP-Sepharose. Twenty-five to 40% of the PH]QNB
binding activity in the solubilized fraction was recovered
after the purification. The MBP-Mj mutant was purified
100-fold and the specific activity increased from 5.0-6.5 to
420-650 pmol/mg protein. The Ms mutant expressed in Sf9
cells was purified by the same method with a similar recov-
ery (30-^0% of the' PH]QNB binding activity in the solubi-
lized fraction), and the specific activity increased from 50-
68 to 4,500-6,500 pmol/mg of protein.
Ligand Binding Properties of the MBP-M2 Mutant Com-
pared with the M2 Mutant—Ligand binding properties were
compared between solubilized preparations of the MBP-Mj
mutant and the M^-mutant, which were derived from E.
coli and Sf9 cells, respectively. Both the MBP-Mj mutant
and the M2 mutant showed high affinity for PHIQNB and
PH]NMS (Fig. 4). From Scatchard plots, the Kd and B^
values for PH]QNB and PH]NMS were calculated for the
MBP-M2 mutant and the M2 mutant (Table II). Figure 5
shows displacement curves of PH]QNB binding for carbam-
ylcholine (muscarinic agonist) and atropine (muscarinic
antagonist). The i£, values for carbamylcholine and atro-
pine were calculated from the displacement curve (Table
ID. Both the Kd and K^ values were very similar for the
MBP-Mj mutant and the M-j mutant. These results indicate
that the MBP-Mj mutant expressed in E. coli has the same
ligand binding activity as the M^mutant expressed in Sf9
cells, and that the addition of MBP at the N-terminus of
the Mj mutant does not alter the ligand binding properties.
Interaction of the MBP-M2 Mutant with G Protein Go and
Ga—We examined the ability of the MBP-Mj mutant to
interact with G protein Go and compared it with that of the
Mj mutant. The purified MBP-Mj mutant and the M? mu-
tant were reconstituted with purified G protein Go or G^ in
110K
84.2K
Mj mutant
32.7K
M2 mutant —
25.7K
1 2
«
**
•
m
m
3 4
m
- ^
^m m —
•
Mj mutan
dimer
Fig. 3. Expression of the MBP-M^ mutant. The receptors were
solubilized with 1% Triton X-100 at 4 mg/ml protein concentration.
The solubilized fraction (30 and 3 pi per lane for the preparation de-
rived from E. coli and Sf9, respectively) was subjected to SDS-PAGE
followed by Western blotting with polyclonal antibodies for the
6 xhistidine tag. The MBP-Mj mutant from E. coli (lane 1) and the
Mj mutant from Sf9 (lane 3) have theoretical molecular weights of
approximately 80 and 35 kDa, respectively. No expression of the M,
mutant was observed in E. coli (lane 4). Lane 2 represents a control
that contained the vector without the Mj mutant gene.
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lipid vesicles consisting of PC, PI, and cholesteryl hemisuc-
cinate. Figure 6 shows displacement curves for carbamyl-
choline or atropine as to PH]QNB binding of the
reconstituted vesicles in the presence or absence of 0.1 mM
GTP. For both the MBP-Mj mutant and the ML, mutant, the
displacement curves with carbamylcholine were biphasic in
the absence of GTP and monophasic in the presence of
GTP. The displacement curves with atropine for both the
MBP-mutant and the M^ mutant were monophasic in
either the presence or absence of GTP. The displacement
curves with carbamylcholine in the absence of GTP well fit-
ted the equation for a two-binding site model whereas the
rest of the displacement curves well fitted the equation for
a one-binding site model. The percentages and X, values of
the high and low affinity sites were calculated from the dis-
placement curves (Table DI). The results are consistent
with the previous data obtained on reconstitution of G pro-
teins with the M^ muscarinic receptor purified from porcine
atria (37, 38) or the M^ mutant from Sf9 cells (20), and can
be explained with the same assumption; the Mj muscarinic
receptor interacts with Go in the absence of GTP and the
Mj-G,, complex exhibits higher affinity for carbamylcholine
than the free M^ receptor, whereas M -^G,, and Mj exhibit
the same affinity for atropine. The similarity in the propor-
tions of high affinity sites in the absence of GTP indicate
that the MBP-NLj mutant from E. coli has the same ability
to couple with G protein Go as the Mj mutant from Sf9 (10).
In addition, the similarity in K^ values of carbamylcholine
and atropine indicates that the MBP-Mj mutant expressed
in E. coli and the Mj mutant from Sf9 cells have essentially
the same characteristics as to interaction with both ligands
and G proteins.
The MBP-Mj mutant was then examined as to its ability
to activate Go by measuring the agonist-dependent P^]-
GTPyS binding activity for the reconstituted vesicles (Fig.
7). The vesicles were incubated with 50 nM PSJGTPyS in
4 6
|'H|NMS(nM)
50 100 150 200
|'H|QNB(pM)
250
20 40 60 80
B (fmol)
100 120 140
Fig. 4. Binding of [»H]QNB and PH]NMS with the MBP-M,
mutant from E. coli and the M, mutant from Sf9 cells. The E.
coli (• , solid lines) and Sf9 (O, dotted lines) membrane fractions were
8olubilized with 1% digitonin/0.3% sodium cholate at 2 mg/ml protein
concentration. The solubilized fraction of the M, mutant from Sf9
was diluted 10-fold to adjust the receptor concentration to that of the
MBP-M, mutant Ten microliters each of these fractions was incu-
20 40 60 80
B (fmol)
100 120 140
bated with various concentrations of PH]NMS (a-1) or PHIQNB (a-2)
in 200 ul of a buffer containing 20 mM potassium phosphate buffer
(pH 7.0), 0.1 M NaCl, and 0.1% digitonin at 30'C for 1 h. Each point
represents the average of values determined in duplicate in two dif-
ferent experiments (b-1 and b-2). Scatchard transformation of data in
(a-1) and (a-2).
TABLE II. Affinity of PHINMS and PHIQNB for the MBP-Mj mutant and the Mj mutant The K6 and B m values for PH]NMS and
PHIQNB were calculated from Scatchard plots for the MBP-M, mutant and the Mj mutant in Fig. 4.
PHIQNB PH]NMS (finoV20 jig protein)PHIQNB PHINMS Atropine
K,(uM)
Carbamyicholine
MBP-Mj mutant (£. coli) 27.1
Mj mutant (Sf9) 26.7
1.80
1.57
113
111
130
135
0.44
0.30
46.2
25.2
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the presence of 5 uM GDP and carbamylcholine or atro-
pine. For both the MBP-Mj mutant and the Mj mutant, the
extent of P'SJGTPyS binding was greater in the presence of
carbamylcholine than in the presence of atropine. These
results are also consistent with the previous ones obtained
for the Mj receptor derived from mammalian tissues (37,
38) or Sf9 cells (10), and indicate that the agonist-bound
MBP-IVL, mutant can facilitate the binding of PSlGTPyS to
Go in the presence of GDP in the same way as the M^
mutant.
The MBP-Mj mutant was also shown to interact with
and activate G protein Ga. Figure 8a shows the PHJQNB
binding activity of the reconstituted vesicles of the MBP-Mj
mutant and Ga in the presence of various concentrations of
carbamylcholine and atropine, and in the presence or
absence of 0.1 mM GTP. As with G protein G^ the displace-
ment curve with carbamylcholine in the absence of GTP
well fitted the equation for a two-binding site model
whereas the rest of the displacement curves well fitted the
equation for a one-binding site model. The percentages and
.Kj values of the high and low affinity sites were calculated
from the displacement curves (Table HI). The ability of the
MBP-Mj mutant to activate Ga was also demonstrated as
stimulation by carbamylcholine of the [^SjGTPyS binding
activity of the reconstituted vesicles in the presence of GDP
(Fig. 8b).
Figure 9 shows the displacement curves for GDP of
P'SlGTPyS binding in the presence of carbamylcholine or
'-12 -10 - 8 - 6 - 4
Log|Ligand| (M) -2 0
Fig. 5. Displacement of L'HJQNB by carbamylcholine and at-
ropine. The experimental conditions were the same as those given
in the legend to Fig. 3, except that a single concentration of
PH]QNB (1.5 nM), and different concentrations of carbamylcholine
(A, A) and atropine (O, • ) were incubated with the solubilized MBP-
Mj mutant (A, • , solid lines) and Mj mutant (A, O, dotted lines). The
graphs shown are each representative of four experiments. The ac-
tual value for 100% is 5,000 to 6,000 dpm.
-12 -10 - 8 - 6 - 4 - 2
Log[Ug«nd| (M)
-10 - 8 - 6 - 4 - 2 0
Log[Ligand] (M)
Fig. 6. Interaction of the MBP-M, mutant and the M, mutant
with G protein Go. The MBP-NL, mutant (a) and the Mj mutant
(b) were solubilized from E. coli and Sf9 membranes, respectively,
purified, and then reconstituted into lipids with Go purified from
porcine brain. The reconstituted vesicles containing 100 fmol of the
MBP-Mj mutant or the Mj mutant in a 50 ul volume were incu-
bated with 950 ul of buffer containing 1.5 nM PHJQNB in the pres-
ence of carbamylcholine ( O , • ) or atropine ( A , A ), and in the
presence ( A , • ) or absence ( A , O) of 0.1 mM GTP at 30'C for 1 h.
Displacement curves in the presence of carbamylcholine and in the
absence of GTP well fitted the equation for a two-site model
whereas the rest of the displacement curves well fitted the equation
for a one-site model. The equation for the two-site model was Y =
AlCJLVUC + ICM(L)) + (100 - A)IC60(Hytt: + IC^CH)), where A is
the percentage of low-affinity sites, IC^H) and ICW(L) the concen-
trations of carbamylcholine giving half-maximal effects on the
t*H]QNB as to the high- and low-affinity sites, respectively, andX
the concentration of carbamylcholine. The equation for the one-site
model was Y = \0ff\CJOC + IC ,^). The graphs shown are each rep-
resentative of four experiments.
TABLE IE. Affinity of carbamylcholine and atropine for the MBP-Mj mutant and the Mj mutant reconstituted with G proteins.
The K, values for carbamylcholine and atropine were calculated from the data in Figs. 6, 7, and 9. Abbreviations: (H), high-affinity binding site;
(L), low-affinity binding site.
MBP-Mj mutant-G.
(E. coli) (PC/PI/Cholesterol)
Mj mutant-G
(Sf9) (PC/PI/Cholesterol)
MBP-Mj mutant-Go
(E. coli) (PCVPI)
MBP-Mj mutant-G,,
(£. coli) (PCVPI/Cholesterol)
GTP(
0.69
0.84
—
0.77
-) GTP(+)
0.85
0.59
—
0.65
AC. (carbamylcholine)
— ^ H T
15.3
18.9
21.5
134.0
GTP(-)
7.99
10.0
6.76
7.43
GTP(+)
4.34
6.60
14.1
7.2
Proportion of
high-affinity
sites (%)
58.7
56.8
58.7
68.8
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Fig. 7. Stimulation of ["SIGTPyS binding to G protein Go re-
constituted with the MBP-M, mutant or the M, mutant. Go
and the MBP-Mj mutant from E. coli (a) or the Mj mutant from Sf9
(b) were reconstituted into lipids as described in the legend to Fig.
5. The reconstituted vesicles containing 100 finol of the MBP-W^
mutant or the M, mutant were incubated with 50 nM [*S]GTP|S
and 5 uM GDP in the presence of 1 mM carbamylcholine (O) or 10
uM atropine ( • ). The graphs shown are each representative of four
experiments.
atropine for reconstituted vesicles of the MBP-Mj mutant
with Go or G,,. In vesicles containing either Go or Gil; the
displacement curves in the presence of carbamylcholine
shifted to the right compared to the ones in the presence of
atropine. The ICM values of GDP in the presence of car-
bamylcholine and atropine were estimated to be 4.11 and
0.24 uM for Gu, and 37.2 and 2.04 uM for Gw respectively.
The differences in IC^, values between carbamylcholine
and atropine were 17.1-fold in Gn and 18.2-fold in Go. These
results indicate that the agonist-bound receptor exhibits
17-19 fold lower affinity for GDP than the antagonist-
bound receptor, and that the carbamylcholine-bound MBP-
Mj mutant interacts with both Go and G^.
Effect of Cholesterol on the Interaction of the MBP-M2
Mutant with G Protein Go—The MBP-M^ mutant and G
protein Go were reconstituted into lipid vesicles without
cholesteryl hemisuccinate. The displacement of PH]QNB
binding by carbamylcholine was assessed in the same way
as described previously. The displacement curve in the
presence of GTP well fitted the equation for a one-binding
site model, whereas that in the absence of GTP well fitted
the equation for a two-binding site model (Fig. 10a). The
percentages and K^ values of the high and low affinity sites
were calculated from the displacement curves (Table III).
The similarity in the percentages and K^ values showed
10 IS
Time (mln)
Fig. 8. Interaction of the MBP-M, mutant with and stimula-
tion of ["SlGTPyS binding to G protein Gn. The MBP-Mj mu-
tant was reconstituted into lipids with Gn purified from porcine
brain. The reconstituted vesicles containing 100 fmol of the MBP-Mj
mutant or the Mj mutant in a 50 ul volume were incubated with 950
ul of buffer containing 1.5 nM PH1QNB in the presence of carbam-
ylcholine (o, • lo r atropine (A, A), and in the presence (A, • ) or ab-
sence ( A , O ) of 0.1 mM GTP at 30'C for 1 h. Curve fitting was
performed as described in the legend to Fig. 5 (a). The reconstituted
vesicles containing 100 fmol of the MBP-Mj mutant were incubated
with 50 nM P'SlGTPvS and 5 uM GDP in the presence of 1 mM car-
bamylcholine (o) or 10 uM of atropine (•) (b). The graphs shown are
each representative of three experiments.
that the MBP-M^ mutant reconstituted into cholesterol-
containing vesicles and cholesterol-free vesicles had the
same ability to associate with G protein Go.
The reconstituted vesicles were also examined as to their
ability to bind P^lGTPyS in the presence of carbamylcho-
line or atropine as described previously. In both cholesterol-
containing (Fig. 7a) and cholesterol-free vesicles (Fig. 10b),
the extent of [^SJGTPyS binding was greater in the pres-
ence of carbamylcholine than in the presence of atropine.
These results indicate that cholesterol is not required for
the MBP-Mj mutant to interact with and activate G pro-
tein Go.
DISCUSSION
In this study, we have shown that the MBP-M^ mutant
expressed in E. coli has the ability to interact with both
muscarinic ligands and G proteins Go and Ga.
Fusion of MBP was necessary for functional expression.
The MBP could not be replaced by GST or a leader se-
quence, pelB. Expression of the pel B-ftt, mutant was not
detected on Western blotting while expression of the GST-
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-7 -6 -5
Log|GDP| (M)
Fig. 9. Displacement of ["SJGTPyS by GDP in the presence of
carbamylcholine or atropine. The MBP-Mj mutant was recon-
stituted into lipids with G protein Go or G,! as described in the leg-
end to Fig. 5. The reconstituted vesicles containing 100 finol of the
MBP-M, mutant were inc ubated with 50 nM f^ SlGTPyS (15,000
cpm/50 ul reaction buffer) and various concentrations of GDP in the
presence of 1 mM carbamylcholine (O, A ) or 10 uM atropine ( • , A)
at 30*C for 30 min. The graphs shown are each representative of
three experiments. ( A , A ) represent the data points for Gw and ( • ,
O ) these for G,,.
Mj mutant was detected on Western blotting, but no
PH]QNB binding activity was detected. These results sug-
gest that fusion of a periplasmic protein, MBP, but not a
cytosolic protein, GST, is required for the membrane trans-
location and proper folding of the Mj receptor in mem-
branes. MBP is secreted in a SecB-dependent manner and
the MBP fusion receptor is thought to manipulate this
secretional machinery to translocate itself to the E. coli
inner membrane (30). The expression level was sensitive to
the induction temperature; a low induction temperature is
necessary as in the case of the neurotensin receptor (16) or
cytochrome b6 (39). In addition, the use of different promot-
ers resulted in different expression levels. The expression
level of the MBP-M,; mutant under the T7 promoter
(PET25b) was half that of the MBP-Mj mutant under the
lac promoter when cells were cultured under the same con-
ditions. The lac promoter is a much weaker promoter than
the T7 promoter. The preference for a low temperature and
a weaker promoter implies that a slow transcription rate is
critical for expression of a great amount of functional recep-
tors. This is consistent with the suggestion of Grisshammer
and Tate that slow transcription is essential for proper fold-
ing of the MBP-neurotensin fusion receptor into mem-
branes (23).
Other GPCRs such as the substance K receptor (40) and
the M[ muscarinic receptor (18) have been reported to be
expressed functionally in terms of ligand binding activity
on fusion of MBP to their N-termini. To our knowledge,
however, the MBP fusion receptors including the neuro-
tensin receptor have not been examined as to their ability
to interact with G proteins. In the present study, we solubi-
lized and partially purified the MBP-Mj mutant, and recon-
stituted it with purified G protein Go or Ga into phos-
pholipids vesicles. Using the reconstituted vesicles, we have
provided direct evidence that the MBP-M; mutant
expressed in E. coli retains the ability to interact with and
activate Go and Gn, and that there is virtually no difference
in the affinity for muscarinic ligands and the ability to
interact with Go between the MBP-Mj mutant and the Mj
-8 -6 -4 -2
Log[Carbamylchollne] (M)
6000
10 15
Time (min)
Fig. 10. Interaction of the MBP-M, mutant with and stimula-
tion of ["SIGTPyS binding to G protein Go in the absence of
cholesterol. The MBP-Mj mutant and Go were reconstituted into
lipids consisting of phosphatidylcholine and phosphatidylinositol
[50:50(w/w)] only. The experimental conditions were the same as
those given in the legend to Fig. 5, except that cholesteryl hemisuc-
cinate was omitted. Incubation was carried out in the presence ( • )
or absence ( o ) of 0.1 mM GTP (a). The reconstituted vesicles con-
taining 100 fmol of the MBP-Mj mutant were incubated with 50 nM
["SlGTPyS and 5 uM GDP in the presence of 1 mM carbamylcholine
(O) or 10 uM atropine ( • ) (b). The graphs shown are each represen-
tative of four experiments.
mutant expressed in the Sf9-baculovirus system. We have
already shown that the Mj mutant expressed in Sf9 cells
has the same ability to interact with muscarinic ligands
and G proteins as the wild type Mj muscarinic receptor
purified from porcine atria (10). Thus, we conclude that the
MBP-Mj mutant has the same ability as the mammalian
Mj receptor. E. coli will be the simplest and the least expen-
sive means of producing functionally active GPCRs.
The Mj, mutant expressed in Sf9 cells has been shown to
be palmitoylated at cysteine residue in its C-terrninal tail
(41). Although palmitoylation at cysteine residues has not
been observed in E. coli, the MBP-M^ mutant from E. coli
showed the same ability to interact with G proteins as the
M2 mutant from Sf9 cells. This indicates that palmitoyla-
tion is not necessary for the function of the muscarinic
receptor. On the other hand, the Mj mutant, whose rele-
vant cysteine residue is substituted with an alanine resi-
due, showed the ability to interact with and activate G
protein Ga, but with less activating ability than the palmi-
toylated receptor (41). Several explanations for this discrep-
ancy are possible, as follows. One explanation is that the
reduced ability of the Mj mutant was caused by replace-
ment of the cysteine residue by an alanine residue, but not
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by the lack of palmitoylation. Another possible explanation
is that the unpalmitoylated receptor purified from Sf9 cells
is less stable and is recovered in a lower yield on reconstd-
tutdon compared to the palmitoylated receptor, whereas the
unpalmitoylated receptor purified from E. coli is stable and
recovered in the same yield as the palmitoylated receptor.
In this respect, it should be noted that the degree of purifi-
cation was ten times higher for the Mj mutant from Sf9
cells than the MBP-Mj mutant from E. coli, and that the
highly purified receptor becomes more unstable during the
reconstitution procedure than the less purified receptor.
The present finding is compatible with the report that the
function of the Mj mutant in Chinese hamster ovary (CHO)
cells is not affected by the presence or absence of palmitoy-
lation (42).
Lipids of E. coli membranes comprise 70% phosphati-
dylethanolamine, 15% phosphatidylglycerol, and 15% car-
diolipin (wAv), and are different from those of mammalian
or Sf9 cell membranes, particularly in that they do not con-
tain cholesterol (29). The present results suggest that the
function of the NL, receptor is not affected by lipid environ-
ment of membranes. Our results provide direct evidence
that choresterol is not required for the interaction of the M?
muscarinic receptor with muscarinic ligands and G pro-
teins. Strictly speaking, we cannot exclude the possibility
that cholesterol was copurified with G proteins which were
purified from porcine brain. This, however, is not likely
because G proteins are not integral membrane proteins
with transmembrane segments.
In summary, we have shown that the functional 1VL, mus-
carinic receptor can be expressed in E. coli when MBP is
fused to its N-terminus. The MBP-fused receptor possesses
the same ligand binding activity and ability to interact
with G proteins as the ftL, muscarinic receptor expressed in
Sf9 cells. We have also shown that cholesterol and palmi-
toylation are not essential for the function of the muscar-
inic receptor.
We wish to thank Dr. R. Grisshammer for the pRG/II-MBP vector;
Dr. S. Ishii for the pT-Trx vectors; Dr. K. Shiozaki for the G protein
Go and Gn; Dr. Hayashi for the Pucl9-Mj mutant; Dr. K. Haga for
the help in the receptor reconstitution, and Dr. Touhara for the
help in the DNA work and discussions.
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